Startups
At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company’s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.
Overview
Location
United States, Washington
Employees
11-50
Total raised
$28M
Founded date
2013
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Keiretsu Forum | keiretsuforum.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jul 9, 2020 | Series C round | $14M | |
| Oct 31, 2017 | Series B round | $5.5M | |
| Aug 20, 2014 | Funding round | $3M |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 10, 2020 | Medical device startup LumiThera raises $14M to further develop treatment for ocular disorders | (Photo via LumiThera.com) LumiThera, the Poulsbo, Wash.-based medical device startup developing a treatment for ocular disorders and diseases, has raised $14 million in a new funding round, the company announced this week. The company is co... |
| Jul 9, 2020 | LumiThera Raises $14M in Series C Financing | Valeda Light Delivery System LumiThera Inc., a Seattle, WA-based commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, raised approximately $14M an... |
| Jan 14, 2020 | LumiThera Completes Second Tranche of Series C Financing | LumiThera Inc., a Seattle, WA-based commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, closed the 2nd tranche of its Series C round of financing. The company has now rais... |
| Aug 16, 2019 | LumiThera raises cash for medical device that uses light to fight vision loss | LumiThera is developing a medical device for people with age-related macular degeneration. Above, a retina with patterns associated with the disease. (National Institute of Health Photo) Medical device startup LumiThera raised $1.15 million... |
| Nov 1, 2017 | Term Sheet — Wednesday, November 1 | 5 Qs WITH A DEALMAKER You may know Cindy Whitehead as the woman behind Addyi, the women’s libido-enhancing pill dubbed “the female Viagra.” After two failed attempts, she finally got the drug through FDA approval and promptly sold the compa... |
| Oct 31, 2017 | LumiThera Raises $5.5M in Series B Financing | LumiThera Inc., a Seattle, WA-based clinical stage private medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and diseases, completed a Series B round of financing raising $5.5M. The round... |
| Feb 23, 2016 | Northwest angel investment collective Keiretsu doles out $43.5M in 2015 | Photo via Shutterstock. The Keiretsu Forum Northwest announced today in a news release that its regional collective of angel investors poured $43.5 million into 57 companies this past year, making 2015 the biggest year for investments by th... |
| Aug 20, 2014 | LumiThera raising $3M to combat macular degeneration with laser therapy | Such phototherapy is already being used in physiotherapy, chiropractic and sports medicine, directing visible or near-infrared light from a laser to treat the problem points. It’s been deemed useful in a number of applications, particularly... |
| LumiThera | “Home | LumiThera US” |
Show more
Reviews 0
FAQ about LumiThera, Inc.
When was LumiThera, Inc. founded?
LumiThera, Inc. was founded in 2013.
How much funding has LumiThera, Inc. raised?
LumiThera, Inc. has raised $28M in total across 4 funding rounds.
What funding rounds has LumiThera, Inc. raised?
Parsers VC lists 4 funding rounds of LumiThera, Inc., among them a Series C round of $14M on Jul 9, 2020, a Series B round of $5.5M on Oct 31, 2017 and a funding round of $3M on Aug 20, 2014.
Who has invested in LumiThera, Inc.?
Parsers VC lists 2 investors of LumiThera, Inc., among them Keiretsu Forum.
What has the press written about LumiThera, Inc.?
Parsers VC has collected 11 articles mentioning LumiThera, Inc., among them “Medical device startup LumiThera raises $14M to further develop treatment for ocular disorders” (Jul 10, 2020) and “LumiThera Raises $14M in Series C Financing” (Jul 9, 2020).
Is LumiThera, Inc. still active?
Yes, LumiThera, Inc. is active; its latest activity on Parsers VC dates from Jul 13, 2020.